List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoperfusion Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoperfusion Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Activated Carbon Adsorption
1.4.3 Resin Adsorption
1.5 Market by Application
1.5.1 Global Hemoperfusion Market Share by Application: 2022-2027
1.5.2 Hepatic Encephalopathy
1.5.3 Certain Autoimmune Diseases
1.5.4 Drug Overdose
1.5.5 Specific Intoxications
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Hemoperfusion Market
1.8.1 Global Hemoperfusion Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Hemoperfusion Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hemoperfusion Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hemoperfusion Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Hemoperfusion Sales Volume Market Share by Region (2016-2021)
3.2 Global Hemoperfusion Sales Revenue Market Share by Region (2016-2021)
3.3 North America Hemoperfusion Sales Volume
3.3.1 North America Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.3.2 North America Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Hemoperfusion Sales Volume
3.4.1 East Asia Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Hemoperfusion Sales Volume (2016-2021)
3.5.1 Europe Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Hemoperfusion Sales Volume (2016-2021)
3.6.1 South Asia Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Hemoperfusion Sales Volume (2016-2021)
3.7.1 Southeast Asia Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Hemoperfusion Sales Volume (2016-2021)
3.8.1 Middle East Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Hemoperfusion Sales Volume (2016-2021)
3.9.1 Africa Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Hemoperfusion Sales Volume (2016-2021)
3.10.1 Oceania Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Hemoperfusion Sales Volume (2016-2021)
3.11.1 South America Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.11.2 South America Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Hemoperfusion Sales Volume (2016-2021)
3.12.1 Rest of the World Hemoperfusion Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Hemoperfusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Hemoperfusion Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Hemoperfusion Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Hemoperfusion Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Hemoperfusion Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Hemoperfusion Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Hemoperfusion Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Hemoperfusion Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Hemoperfusion Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Hemoperfusion Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Hemoperfusion Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Hemoperfusion Sales Volume Market Share by Type (2016-2021)
14.2 Global Hemoperfusion Sales Revenue Market Share by Type (2016-2021)
14.3 Global Hemoperfusion Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Hemoperfusion Consumption Volume by Application (2016-2021)
15.2 Global Hemoperfusion Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Hemoperfusion Business
16.1 Jafron Biomedical
16.1.1 Jafron Biomedical Company Profile
16.1.2 Jafron Biomedical Hemoperfusion Product Specification
16.1.3 Jafron Biomedical Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Baxter (Gambro)
16.2.1 Baxter (Gambro) Company Profile
16.2.2 Baxter (Gambro) Hemoperfusion Product Specification
16.2.3 Baxter (Gambro) Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Asahi-Kasei
16.3.1 Asahi-Kasei Company Profile
16.3.2 Asahi-Kasei Hemoperfusion Product Specification
16.3.3 Asahi-Kasei Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Biosun Medical
16.4.1 Biosun Medical Company Profile
16.4.2 Biosun Medical Hemoperfusion Product Specification
16.4.3 Biosun Medical Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Kaneka
16.5.1 Kaneka Company Profile
16.5.2 Kaneka Hemoperfusion Product Specification
16.5.3 Kaneka Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Toray Medical
16.6.1 Toray Medical Company Profile
16.6.2 Toray Medical Hemoperfusion Product Specification
16.6.3 Toray Medical Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Cytosorbents
16.7.1 Cytosorbents Company Profile
16.7.2 Cytosorbents Hemoperfusion Product Specification
16.7.3 Cytosorbents Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Aier
16.8.1 Aier Company Profile
16.8.2 Aier Hemoperfusion Product Specification
16.8.3 Aier Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Zibo Kangbei
16.9.1 Zibo Kangbei Company Profile
16.9.2 Zibo Kangbei Hemoperfusion Product Specification
16.9.3 Zibo Kangbei Hemoperfusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Hemoperfusion Manufacturing Cost Analysis
17.1 Hemoperfusion Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Hemoperfusion
17.4 Hemoperfusion Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Hemoperfusion Distributors List
18.3 Hemoperfusion Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Hemoperfusion (2022-2027)
20.2 Global Forecasted Revenue of Hemoperfusion (2022-2027)
20.3 Global Forecasted Price of Hemoperfusion (2016-2027)
20.4 Global Forecasted Production of Hemoperfusion by Region (2022-2027)
20.4.1 North America Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.3 Europe Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.7 Africa Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.9 South America Hemoperfusion Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Hemoperfusion Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Hemoperfusion by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Hemoperfusion by Country
21.2 East Asia Market Forecasted Consumption of Hemoperfusion by Country
21.3 Europe Market Forecasted Consumption of Hemoperfusion by Countriy
21.4 South Asia Forecasted Consumption of Hemoperfusion by Country
21.5 Southeast Asia Forecasted Consumption of Hemoperfusion by Country
21.6 Middle East Forecasted Consumption of Hemoperfusion by Country
21.7 Africa Forecasted Consumption of Hemoperfusion by Country
21.8 Oceania Forecasted Consumption of Hemoperfusion by Country
21.9 South America Forecasted Consumption of Hemoperfusion by Country
21.10 Rest of the world Forecasted Consumption of Hemoperfusion by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
